FIELD: medicine, pharmacy. SUBSTANCE: suppository (mass is 1.66-1.84 g) has the following components, g: nitazol 0.11-0.13; solid fat or Vitepsol 1.535-1.625, and emulsifier (glycerol monostearate) 0.015-0.085. EFFECT: enhanced effectiveness of treatment, decreased adverse effect. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| VAGINAL SUPPOSITORY SHOWING ANTIMICROBIAL EFFECT | 1997 |
|
RU2115412C1 |
| TREATMENT-AND-PROPHYLACTIC PREPARATION "GEKSIKON" WITH ANTIBACTERIAL AND ANTISEPTIC ACTION | 1999 |
|
RU2166314C2 |
| RECTAL AND VAGINAL SUPPOSITORY SHOWING ANTIBACTERIAL, ANTIVIRAL AND ANTIINFLAMMATORY ACTION AND A METHOD OF ITS MAKING | 1996 |
|
RU2102977C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING UROGENITAL DISEASES | 2008 |
|
RU2375064C1 |
| MEDICINAL AGENT SHOWING ANABOLIC AND ANTIINFLAMMATORY EFFECT | 1996 |
|
RU2108778C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING UROGENITAL INFECTIONS | 2008 |
|
RU2401102C2 |
| SUPPOSITORY EXHIBITING ANTIFUNGAL EFFECT (VARIANTS) | 1996 |
|
RU2139707C1 |
| DRUG FOR TREATMENT OF PATIENT WITH PROCTOLOGICAL DISEASES | 1998 |
|
RU2151592C1 |
| RECTAL SUPPOSITORIES FOR TREATMENT OF PEDIATRIC PATIENTS | 1997 |
|
RU2128987C1 |
| BASE FOR SUPPOSITORY | 0 |
|
SU1364339A1 |
Authors
Dates
1998-07-10—Published
1997-04-22—Filed